Migraine: translational challenges, novel therapies and disease modification

Abstract Migraine is the most common neurological disorder, which after stroke confers the greatest neurological disability in the working population. As with other disorders of brain function, pathophysiological processes are more difficult to delineate, notwithstanding the biological complexities and clinical heterogeneity of the disorder. The current review will outline the framework upon which mechanistic pathways have been predicated. It will examine bench to bedside models: what we have learned from those which have been unsuccessful and address those which have borne fruit, presenting the clinical and exploratory insights gained. In the second part the more recent successes in drug therapeutics are summarised, from clinical trials to real world observations and limitations. With this in sight, the third part emphasises the need to reframe goals towards longer-term disease modification, addressing the impact of confounding comorbidities and moving towards a biopsychosocial model of pain.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2026-11-13
DOI
https://doi.org/10.1007/s00415-026-14231-z
Primary Topic
Migraine and Headache Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Migraine: translational challenges, novel therapies and disease modification

Anish Bahra, Alexandre Mathy, Leah Mistry
Journal of Neurology
Migraine and Headache Studies
article

Migraine: translational challenges, novel therapies and disease modification

Anish Bahra, Alexandre Mathy, Leah Mistry
article en

Abstract

Abstract Migraine is the most common neurological disorder, which after stroke confers the greatest neurological disability in the working population. As with other disorders of brain function, pathophysiological processes are more difficult to delineate, notwithstanding the biological complexities and clinical heterogeneity of the disorder. The current review will outline the framework upon which mechanistic pathways have been predicated. It will examine bench to bedside models: what we have learned from those which have been unsuccessful and address those which have borne fruit, presenting the clinical and exploratory insights gained. In the second part the more recent successes in drug therapeutics are summarised, from clinical trials to real world observations and limitations. With this in sight, the third part emphasises the need to reframe goals towards longer-term disease modification, addressing the impact of confounding comorbidities and moving towards a biopsychosocial model of pain.

Journal of NeurologyVol. 273(12)
Great Western Hospital (GB), John Radcliffe Hospital (GB), University of Oxford (GB), Oxford University Hospitals NHS Trust (GB), National Hospital for Neurology and Neurosurgery (GB)
Migraine and Headache Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon